Credit rating affirmed at IND A+ with Positive outlook by India Ratings

Credit & Debt View source PDF Explain this filing

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.1%Reaction day

₹18980.00

prior close

₹18998.00

announcement price

After-mkt

timing

Nifty Smallcap 250market-1.1%+1.2% vs market

Pharmaceuticals peers, median of 166sector-0.3%+0.4% vs sector

On the reaction day the stock moved 1.2 pts more than Nifty Smallcap 250 and 0.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

-0.5

15m

-0.2

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.1-1.1+1.2-0.3+0.4

Next day

+0.7-0.4+1.1-0.3+0.9

-0.9-0.3-0.6-0.3-0.7

-3.0-0.9-2.0-1.3-1.7

+0.3-0.8+1.1-0.8+1.1

-0.4-0.4-0.0-0.7+0.3

-2.6-2.9+0.3-2.9+0.3

15d

+1.3+0.1+1.2-2.1+3.5

+22.9+0.6+22.3-0.9+23.8

+18.3-1.5+19.8-1.1+19.4

+6.6-1.9+8.4-2.7+9.3

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 166Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

India Ratings and Research has affirmed Neuland Laboratories' bank loan facility rating at IND A+ for long-term and IND A1 for short-term, with a Positive outlook. An affirmation means the existing rating stands unchanged. The Positive outlook indicates the agency may consider an upgrade in future reviews if conditions remain supportive.

Likely market impact

Rating stability with Positive outlook reflects financial health; no change in rating this time but possible upgrade ahead.